4 assets in Acquired Idiopathic Inflammatory Myopathy

Therapeutic assets addressing Acquired Idiopathic Inflammatory Myopathy, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cyclophosphamide Acquired Idiopathic Inflammatory Myopathy	Tongji Hospital	P2/3	BB (65)
Fludarabine Acquired Idiopathic Inflammatory Myopathy	Tongji Hospital	P1	CC (43)
Universal Cd19 Car-Γδt Cell Acquired Idiopathic Inflammatory Myopathy	Tongji Hospital	P1	CC (43)
RD06-05 CART Cell Acquired Idiopathic Inflammatory Myopathy	The Children's Hospital of Zhejiang University School of Medicine	Early P1	C (39)